Larvol Delta - New-evidence-in-the-management-of-CMV-infection-impact-on-prophylaxis-and-treatment

Prevymis (letermovir) - Merck (MSD)

Livtencity (maribavir) - Takeda, GSK

http://www.ncbi.nlm.nih.gov/pubmed/41159235

Jesús Fortún

Oct 29, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next